Skip to main content
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.570
+0.110 (4.47%)
At close: Feb 27, 2026, 4:00 PM EST
2.590
+0.020 (0.78%)
After-hours: Feb 27, 2026, 6:16 PM EST

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $15.17M in the quarter ending December 31, 2025, a decrease of -6.51%. This brings the company's revenue in the last twelve months to $62.64M, up 2.00% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

Revenue (ttm)
$62.64M
Revenue Growth
+2.00%
P/S Ratio
0.44
Revenue / Employee
$754,699
Employees
83
Market Cap
27.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-8.62M-11.67%
Jun 30, 202373.80M-22.87M-23.66%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 75.58M
InterCure 72.16M
Biofrontera 37.16M
Zhengye Biotechnology Holding 21.46M
SCYNEXIS 2.93M
TherapeuticsMD 2.80M
BioXcel Therapeutics 752.00K
Talphera 28.00K
Revenue Rankings

AYTU News

More News